Acumen Pharmaceuticals
Executives
View the org chart displaying its 32 main executives
Most searched biographies at Acumen Pharmaceuticals
- Daniel O'Connell, President & Chief Executive Officer
- Nathan Fountain, Director
- Sean Stalfort, Chairman of the Board
Popular executive movements at Acumen Pharmaceuticals
- James Doherty has joined the company as President and Chief Development Officer (posted on February 2 2024).
Create your alert
to follow the executive moves at Acumen Pharmaceuticals.
Pharmaceuticals
Acumen Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Acumen Pharmaceuticals
- X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023 | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Appointment of Industry Veteran R. Keith Woods to Board of Directors | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U.S. FDA for Mavorixafor in WHIM Syndrome | X4 Pharmaceuticals, Inc.
- News Releases | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals to Participate in the Cantor Global Healthcare Conference | X4 Pharmaceuticals, Inc.
- View more press releases Close
Social media about Acumen Pharmaceuticals
- Acumen Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Acumen Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Daniel O'Connell 
Call Acumen Pharmaceuticals at +1 650...
